231 related articles for article (PubMed ID: 19426699)
1. Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose.
Ghanem CI; Ruiz ML; Villanueva SS; Luquita M; Llesuy S; Catania VA; Bengochea LA; Mottino AD
Biochem Pharmacol; 2009 May; 77(10):1621-8. PubMed ID: 19426699
[TBL] [Abstract][Full Text] [Related]
2. Shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats.
Ghanem CI; Ruiz ML; Villanueva SS; Luquita MG; Catania VA; Jones B; Bengochea LA; Vore M; Mottino AD
J Pharmacol Exp Ther; 2005 Dec; 315(3):987-95. PubMed ID: 16109740
[TBL] [Abstract][Full Text] [Related]
3. Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats.
Villanueva SS; Ruiz ML; Ghanem CI; Luquita MG; Catania VA; Mottino AD
Drug Metab Dispos; 2008 Mar; 36(3):475-80. PubMed ID: 18096675
[TBL] [Abstract][Full Text] [Related]
4. Ethynylestradiol increases expression and activity of rat liver MRP3.
Ruiz ML; Villanueva SS; Luquita MG; Vore M; Mottino AD; Catania VA
Drug Metab Dispos; 2006 Jun; 34(6):1030-4. PubMed ID: 16554369
[TBL] [Abstract][Full Text] [Related]
5. Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease.
Lickteig AJ; Fisher CD; Augustine LM; Aleksunes LM; Besselsen DG; Slitt AL; Manautou JE; Cherrington NJ
Drug Metab Dispos; 2007 Oct; 35(10):1970-8. PubMed ID: 17640958
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
[TBL] [Abstract][Full Text] [Related]
7. Transport deficient (TR-) hyperbilirubinemic rats are resistant to acetaminophen hepatotoxicity.
Silva VM; Thibodeau MS; Chen C; Manautou JE
Biochem Pharmacol; 2005 Dec; 70(12):1832-9. PubMed ID: 16271353
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice.
Lin MC; Wang EJ; Patten C; Lee MJ; Xiao F; Reuhl KR; Yang CS
J Biochem Toxicol; 1996; 11(1):11-20. PubMed ID: 8806047
[TBL] [Abstract][Full Text] [Related]
9. Alteration in metabolism and toxicity of acetaminophen upon repeated administration in rats.
Kim SJ; Lee MY; Kwon DY; Kim SY; Kim YC
J Pharmacol Sci; 2009 Oct; 111(2):175-81. PubMed ID: 19834287
[TBL] [Abstract][Full Text] [Related]
10. Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.
Canet MJ; Merrell MD; Hardwick RN; Bataille AM; Campion SN; Ferreira DW; Xanthakos SA; Manautou JE; A-Kader HH; Erickson RP; Cherrington NJ
Drug Metab Dispos; 2015 Jun; 43(6):829-35. PubMed ID: 25788542
[TBL] [Abstract][Full Text] [Related]
11. Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene.
Manautou JE; de Waart DR; Kunne C; Zelcer N; Goedken M; Borst P; Elferink RO
Hepatology; 2005 Nov; 42(5):1091-8. PubMed ID: 16250050
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity.
Dambach DM; Durham SK; Laskin JD; Laskin DL
Toxicol Appl Pharmacol; 2006 Mar; 211(2):157-65. PubMed ID: 16081117
[TBL] [Abstract][Full Text] [Related]
13. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein.
Ghanem CI; Gómez PC; Arana MC; Perassolo M; Ruiz ML; Villanueva SS; Ochoa EJ; Catania VA; Bengochea LA; Mottino AD
Biochem Pharmacol; 2004 Aug; 68(4):791-8. PubMed ID: 15276087
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage.
Abdel-Zaher AO; Abdel-Rahman MM; Hafez MM; Omran FM
Toxicology; 2007 May; 234(1-2):124-34. PubMed ID: 17391827
[TBL] [Abstract][Full Text] [Related]
15. Protection against acetaminophen hepatotoxicity by a single dose of clofibrate: effects on selective protein arylation and glutathione depletion.
Manautou JE; Emeigh Hart SG; Khairallah EA; Cohen SD
Fundam Appl Toxicol; 1996 Feb; 29(2):229-37. PubMed ID: 8742320
[TBL] [Abstract][Full Text] [Related]
16. Effects of administration of subtoxic doses of acetaminophen on liver and blood levels of insulin-like growth factor-1 in rats.
Ozdemir D; Aksu I; Baykara B; Ates M; Sisman AR; Kiray M; Buyuk A; Uysal N
Toxicol Ind Health; 2016 Jan; 32(1):39-46. PubMed ID: 23907830
[TBL] [Abstract][Full Text] [Related]
17. Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes.
Aleksunes LM; Campion SN; Goedken MJ; Manautou JE
Toxicol Sci; 2008 Aug; 104(2):261-73. PubMed ID: 18468992
[TBL] [Abstract][Full Text] [Related]
18. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation.
James LP; McCullough SS; Lamps LW; Hinson JA
Toxicol Sci; 2003 Oct; 75(2):458-67. PubMed ID: 12883092
[TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
Shankar K; Vaidya VS; Apte UM; Manautou JE; Ronis MJ; Bucci TJ; Mehendale HM
Toxicol Sci; 2003 Jun; 73(2):220-34. PubMed ID: 12700423
[TBL] [Abstract][Full Text] [Related]
20. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]